881 related articles for article (PubMed ID: 26574876)
1. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate.
Rademakers KL; van Koeveringe GA; Oelke M
Curr Opin Urol; 2016 Jan; 26(1):3-10. PubMed ID: 26574876
[TBL] [Abstract][Full Text] [Related]
2. Unravelling detrusor underactivity: Development of a bladder outlet resistance-Bladder contractility nomogram for adult male patients with lower urinary tract symptoms.
Oelke M; Rademakers KL; van Koeveringe GA;
Neurourol Urodyn; 2016 Nov; 35(8):980-986. PubMed ID: 26235823
[TBL] [Abstract][Full Text] [Related]
3. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies.
Gammie A; Kaper M; Dorrepaal C; Kos T; Abrams P
Eur Urol; 2016 Feb; 69(2):361-9. PubMed ID: 26318706
[TBL] [Abstract][Full Text] [Related]
4. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia.
Kang M; Kim M; Choo MS; Bae J; Ku JH; Yoo C; Oh SJ
Urology; 2014 Dec; 84(6):1461-6. PubMed ID: 25432841
[TBL] [Abstract][Full Text] [Related]
5. Detrusor contraction power parameters (BCI and W max) rise with increasing bladder outlet obstruction grade in men with lower urinary tract symptoms: results from a urodynamic database analysis.
Oelke M; Rademakers KL; van Koeveringe GA
World J Urol; 2014 Oct; 32(5):1177-83. PubMed ID: 25007993
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume.
Oelke M; Höfner K; Jonas U; de la Rosette JJ; Ubbink DT; Wijkstra H
Eur Urol; 2007 Sep; 52(3):827-34. PubMed ID: 17207910
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms.
Malde S; Nambiar AK; Umbach R; Lam TB; Bach T; Bachmann A; Drake MJ; Gacci M; Gratzke C; Madersbacher S; Mamoulakis C; Tikkinen KAO; Gravas S;
Eur Urol; 2017 Mar; 71(3):391-402. PubMed ID: 27687821
[TBL] [Abstract][Full Text] [Related]
8. Urodynamic Features and Significant Predictors of Bladder Outlet Obstruction in Patients With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Small Prostate Volume.
Kang M; Kim M; Choo MS; Paick JS; Oh SJ
Urology; 2016 Mar; 89():96-102. PubMed ID: 26683755
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound detrusor wall thickness measurement in combination with bladder capacity can safely detect detrusor underactivity in adult men.
Rademakers KL; van Koeveringe GA; Oelke M;
World J Urol; 2017 Jan; 35(1):153-159. PubMed ID: 27447991
[TBL] [Abstract][Full Text] [Related]
10. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
Jiang YH; Wang CC; Kuo HC
PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
[TBL] [Abstract][Full Text] [Related]
11. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
[TBL] [Abstract][Full Text] [Related]
12. Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction.
Arnolds M; Oelke M
Curr Opin Urol; 2009 Jan; 19(1):55-62. PubMed ID: 19057217
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms.
Matsukawa Y; Yoshida M; Yamaguchi O; Takai S; Majima T; Funahashi Y; Yono M; Sekido N; Gotoh M
Int J Urol; 2020 Jan; 27(1):47-52. PubMed ID: 31542892
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of detrusor underactivity: a short term proof of concept study.
Blaivas JG; Forde JC; Davila JL; Policastro L; Tyler M; Aizen J; Badri A; Purohit RS; Weiss JP
Int Braz J Urol; 2017; 43(3):540-548. PubMed ID: 28266820
[TBL] [Abstract][Full Text] [Related]
15. Post-void residual urine ratio: A novel clinical approach to the post-void residual urine in the assessment of males with lower urinary tract symptoms.
Rubilotta E; Balzarro M; Trabacchin N; Righetti R; D'Amico A; Blaivas JG; Antonelli A
Investig Clin Urol; 2021 Jul; 62(4):470-476. PubMed ID: 34085789
[TBL] [Abstract][Full Text] [Related]
16. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis.
Osman NI; Chapple CR; Abrams P; Dmochowski R; Haab F; Nitti V; Koelbl H; van Kerrebroeck P; Wein AJ
Eur Urol; 2014 Feb; 65(2):389-98. PubMed ID: 24184024
[TBL] [Abstract][Full Text] [Related]
17. Signs and symptoms that distinguish detrusor underactivity from mixed detrusor underactivity and bladder outlet obstruction in male patients.
Gammie A; Kaper M; Steup A; Yoshida S; Dorrepaal C; Kos T; Abrams P
Neurourol Urodyn; 2018 Apr; 37(4):1501-1505. PubMed ID: 29356059
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of holmium laser enucleation of the prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction.
Pyun JH; Kang SG; Kang SH; Cheon J; Kim JJ; Lee JG
Kaohsiung J Med Sci; 2017 Sep; 33(9):458-463. PubMed ID: 28865604
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of benign prostatic obstruction: Development of a clinical nomogram.
De Nunzio C; Autorino R; Bachmann A; Briganti A; Carter S; Chun F; Novara G; Sosnowski R; Thiruchelvam N; Tubaro A; Ahyai S;
Neurourol Urodyn; 2016 Feb; 35(2):235-40. PubMed ID: 25524269
[TBL] [Abstract][Full Text] [Related]
20. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.
Nitti VW; Rosenberg S; Mitcheson DH; He W; Fakhoury A; Martin NE
J Urol; 2013 Oct; 190(4):1320-7. PubMed ID: 23727415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
